Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 8/2021

01-08-2021 | Hashimoto Thyroiditis | Letter to the Editor

Thyroid disorders in familial Mediterranean fever: think about AA amyloidosis!

Authors: Hélène Vergneault, Rim Bourguiba, Samuel Ardois, Anael Dumont, Léa Savey, Gilles Grateau, Sophie Georgin-Lavialle

Published in: Clinical Rheumatology | Issue 8/2021

Login to get access

Excerpt

We read with interest the work of Turan et al. [1] on thyroid disorders in children with familial Mediterranean fever (FMF). The authors have reported that the prevalence of autoimmune thyroiditis is not increased in this population compared to age- and sex-matched healthy controls. In addition with their data, we would like to enhance two points on the link between thyroid and FMF: …
Literature
1.
Turan H, Yildiz M, Civan O, Cakir AD, Tarcin G, Ozer Y et al (2021) Evaluation of the thyroid disorders in children with familial Mediterranean fever. Clin Rheumatol avr 40(4):1473–1478CrossRef
2.
McLeod DSA, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2):252–65CrossRef
3.
Vergneault H, Terré A, Buob D, Buffet C, Dumont A, Ardois S et al (2021) Amyloid goiter in familial mediterranean fever: description of 42 cases from a French cohort and from literature review. Journal of Clinical Medicine janv 10(9):1983CrossRef
4.
von Rokitansky C (1855) Lehrbuch der pathologischen Anatomie: Allgemeine pathologische Anatomie und Anomalien des Blutes, volume 1. In: Braumüller (ed) Wien, pp 326–328
Metadata
Title
Thyroid disorders in familial Mediterranean fever: think about AA amyloidosis!
Authors
Hélène Vergneault
Rim Bourguiba
Samuel Ardois
Anael Dumont
Léa Savey
Gilles Grateau
Sophie Georgin-Lavialle
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 8/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05852-y

Other articles of this Issue 8/2021

Clinical Rheumatology 8/2021 Go to the issue

Original Article

Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean

Clinical Image

Juvenile dermatomyositis with gingival vasculopathy

Review Article

Ankylosing spondylitis risk factors: a systematic literature review

Letters of Biomedical and Clinical Research

Preeclampsia in primary antiphospholipid syndrome is associated with fetal losses and limb ischemia

Original Article

Real world utilization of the myositis autoantibody panel

Retraction Note

Retraction Note: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits